or Try an Advanced Search...

    Morphinans Stocks List

    Symbol Grade Name % Change
    ALKS B Alkermes plc -0.56
    PMD C Psychemedics Corporation -0.64
    INDV C Indivior PLC -3.25
    NKTR D Nektar Therapeutics -8.55
    VRPX F Virpax Pharmaceuticals, Inc. -4.72
    COLL F Collegium Pharmaceutical, Inc. -2.28
    TRVI F Trevi Therapeutics, Inc. -3.85
    DRRX F DURECT Corporation -9.82
    TTNP F Titan Pharmaceuticals, Inc. -4.64
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Opioids Chemical Compounds Euphoriants Organic Compounds Pain Pharmaceutical Schizophrenia Biopharmaceutical Chronic Pain Drug Delivery Drugs Ethers Hydrocodone Hyperactivity Disorder Oxycodone Phenols Analgesics Attention Deficit Hyperactivity Disorder Atypical Antipsychotics Bupivacaine

    Related ETFs - A few ETFs which own one or more of the above listed Morphinans stocks.

    Symbol Grade Name Weight
    PSIL C AdvisorShares Psychedelics ETF 5.29
    MEDX F Horizon Kinetics Medical ETF 3.9
    IBRN C iShares Neuroscience and Healthcare ETF 3.63
    PSCH C PowerShares S&P SmallCap Health Care Portfolio 3.62
    FBT C First Trust Amex Biotech Index Fund 3.2
    View all Morphinans ETFs...
    Compare ETFs
    Compare IBRN to PSCH Compare MEDX to FBT Compare PSIL to MEDX

        Morphinans Stocks Recent News

        Date Stock Title
        Nov 14 NKTR Multiple Catalysts Ahead For Nektar Therapeutics
        Nov 14 DRRX Q3 2024 DURECT Corp Earnings Call
        Nov 14 COLL Collegium Pharmaceutical's (NASDAQ:COLL) Performance Is Even Better Than Its Earnings Suggest
        Nov 14 DRRX Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Cost Reductions and ...
        Nov 14 DRRX DURECT Corporation (DRRX) Q3 2024 Earnings Call Transcript
        Nov 13 DRRX Durect (DRRX) Reports Q3 Loss, Misses Revenue Estimates
        Nov 13 DRRX Durect: Q3 Earnings Snapshot
        Nov 13 DRRX DURECT GAAP EPS of -$0.14 beats by $0.03, revenue of $1.92M misses by $0.06M
        Nov 13 DRRX DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update
        Nov 13 COLL Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now?
        Nov 13 VRPX Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
        Nov 13 DRRX Earnings Scheduled For November 13, 2024
        Nov 12 DRRX DURECT Q3 2024 Earnings Preview
        Nov 12 COLL Collegium to Participate in Upcoming Investor Conferences
        Nov 10 NKTR Nektar Therapeutics (NASDAQ:NKTR) Just Reported And Analysts Have Been Lifting Their Price Targets
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Opioids Chemical Compounds Euphoriants Organic Compounds Pain Pharmaceutical Schizophrenia Biopharmaceutical Chronic Pain Drug Delivery Drugs Ethers Hydrocodone Hyperactivity Disorder Oxycodone Phenols Analgesics Attention Deficit Hyperactivity Disorder Atypical Antipsychotics Bupivacaine
        Morphinans

        Morphinan is the prototype chemical structure of a large chemical class of psychoactive drugs, consisting of opiate analgesics, cough suppressants, and dissociative hallucinogens, among others.

        More about Morphinans
        Browse All Tags